Lab Alert Thresholds: How to Set, Report and Review Them

A lab alert threshold is the result value beyond which a laboratory must notify the clinician instead of simply posting the result. Some thresholds mark life-threatening results that need a call right away. Others mark serious results that need review within a set time. The best lists are written with the clinicians who use them, are reviewed on a schedule, and come with a documented process for what happens after the call.

This guide is for physicians, practice managers, urgent care leaders, long-term care teams and research sponsors. It explains how thresholds work, who decides them, what U.S. rules expect, and what to ask of your laboratory partner.

TL;DR

• An alert threshold is a notification trigger. It is different from a reference interval, which describes typical results, and it can include tiers beyond “critical.”
• In U.S. laboratories the laboratory director sets the list, working with the clinicians and medical staff who use the service.
• CLIA requires immediate alerting of the test requester for panic or alert values. CAP requires written procedures and notification records.
• A good process includes read-back, escalation when no one answers, and tracking of both speed and reliability.
• Review the list at least annually, and tailor it to your patients, such as neonates, dialysis patients or oncology patients.

What a lab alert threshold actually means

Most clinicians know three numbers on a lab report: the reference interval, the flag for abnormal, and the critical value. An alert threshold sits in a different place. It is the point at which the lab stops waiting for you to open the report and contacts you.

The terminology varies. The CLSI guideline GP47 defines two result categories: critical-risk results and significant-risk results. Critical-risk results indicate a possible immediately life-threatening condition and require communication without delay. Significant-risk results are not immediately life-threatening, but they put the patient at risk unless a clinician evaluates them sooner than routine reporting would allow.

A 2024 article in Clinical Chemistry adds a third idea. It separates critical results, significantly abnormal results and critical tests. Critical tests need prompt communication whatever the result, and the article gives ADAMTS13 as an example.

The practical difference is this:

The same terms are used loosely in practice. Some labs say “panic values,” others say “alert values,” and the newer ISO 15189:2022 standard speaks of critical decision limits and clinical decision limits defined by risk to patients. When you evaluate a lab, ask what its list contains and what each tier triggers. Do not rely on the label.

Who sets alert thresholds in the United States

The laboratory director decides which tests go on the list and where the high and low limits sit. A pathology consultation in the American Journal of Clinical Pathology notes that this is done in communication with the clinicians who use the laboratory and, where applicable, the institution’s medical review board. The College of American Pathologists (CAP) says the same: the laboratory medical director creates the list with the approval of the medical staff. CAP also strongly discourages letting clinicians opt out of receiving critical results.

Where the numbers come from

There is no single national list. A 2016 systematic review in Clinical Chemistry found that 70% of papers reported thresholds set by individual institutions. Another 18% drew on surveys of laboratories or clinicians. Six professional bodies had recommended “starter sets,” and three of those were collaborations between pathologists and clinicians.

The same review found that none of the nine outcome studies it identified dealt with confounding factors. That gap in the evidence is one reason local consultation matters. Your lab’s list reflects judgment, literature and the patients it serves.

A consensus statement on high-risk results recommends that thresholds be based on clinical outcome data or expert consensus where it exists, such as national or international guidelines. It also recommends documenting every source used. Nationwide Children’s Hospital describes its own approach: its critical values were built from literature review, consultation with physician groups and historically accepted values, and are reviewed annually and distributed to all medical staff.

Why one list does not fit every patient

A threshold that protects one population can create noise for another. The Clinical Chemistry authors note that a lab can set different potassium thresholds for a hemodialysis unit and different white blood cell thresholds for hematology and oncology. They add that such changes should always be made in close consultation with the responsible clinicians.

The ASCP practice parameter describes category-specific critical values as a way to cut the volume of reporting while still meeting a particular group’s needs. Neonatal bilirubin is its common example. The pathology consultation likewise notes that many laboratories use unique limits for neonates.

For a practice, this means your lab’s list should be a conversation, not a document you receive. A skilled nursing facility, a pediatric office and a men’s health clinic do not have the same risk profile.

What an alert list should contain

The consensus statement is specific about the fields. An alert list should include the test name, the reporting unit, the thresholds (upper, lower and/or delta) and the time frame for notification. The list should be developed with representative clinicians using risk assessment principles.

That gives you a practical template:

• Test and unit. Units matter. A threshold of 7 for potassium means nothing without mmol/L.
• Low and high limits. Some tests only need one direction.
• Delta limits. A large change from the patient’s previous result can matter even when the new value is within range.
• Time frame. The same statement notes that a serum potassium of 7 mmol/L needs immediate communication, while a new hyperthyroid result may be communicated on the next working day.
• Who is called, and who is next. Name the person, the backup and the after-hours route.
• Population rules. Neonates, dialysis, oncology, outpatients.

Keep the list short enough to be taken seriously. The ASCP parameter observes that, on average, reporting a critical value takes about 6 minutes for an inpatient and 14 minutes for an outpatient. It also calls notification for every toxic therapeutic drug level probably excessive. Every unnecessary call uses staff time and trains clinicians to tune calls out.

Some analytes are followed over repeated draws rather than against one cutoff. A bone turnover marker monitoring plan is one example of how repeat measurements are structured over time. If your practice follows tests that way, ask your lab how delta rules apply.

If you also review outliers and implausible values, our guide to outlier detection in lab results covers how those checks fit beside alert rules.

The rules behind critical-result reporting

CLIA

The federal baseline is in the CLIA regulations. Under 42 CFR §493.1291(g), when a result indicates an imminently life-threatening condition, or panic or alert values, the laboratory must immediately alert the test requester and, if applicable, the person responsible for using the results.

CAP and accreditation

CAP checklist item COM.30000 requires written procedures for immediate notification of the responsible clinician when results of designated tests exceed established critical values, and requires records to be kept. For phone calls, CAP says the caller must request and record a read-back. The record must show date and time, the responsible laboratory individual, the person notified and the test results.

The National Patient Safety Goals add that procedures must say by whom and to whom critical results are reported and the acceptable time between availability and reporting, with documentation. GP47 points out that compliance is often a focal point during inspections.

What this means for a practice

You are part of the chain. A lab can only meet its notification duty if it has a correct phone number, a named recipient and an after-hours route. Keep that contact information current and confirm it whenever staffing changes.

What should happen when a result crosses a threshold

A threshold is only as good as the process behind it. The research points to six steps.

1. Verify the result. The lab confirms the result is analytically valid before calling.
2. Notify the responsible person. That means a clinician or designee who can act, not a front-desk voicemail.
3. Read back. The recipient repeats the patient identifiers and the value. CAP requires the read-back be requested and recorded.
4. Document. Date, time, caller, recipient and result.
5. Escalate if no one answers. The pathology consultation describes an escalation policy in which the technologist contacts a supervisor, pathology resident and/or medical director, with a fail-safe mechanism if notification keeps failing.
6. Close the loop clinically. Someone decides what to do for the patient, and that action is recorded.

Timing examples

Time frames are set locally. As one published example, Nationwide Children’s Hospital states that outpatient alert values are called within 2 hours between 7:00 a.m. and 11:00 p.m.. After two unsuccessful attempts to reach the physician, the on-call pathologist is contacted. That may result in contacting the family directly.

CLSI GP47 recommends that all immediately life-threatening results be reported without delay, within a maximum of one hour from verification, and that reliability approach 100% successful reports.

Repeat critical values

Patients with chronically abnormal results can generate the same call day after day. The pathology consultation reports that about 70% of surveyed laboratories have a policy on repeat values, and that there are only three options: call the first value only, call every value, or call once per interval. Agree on one for your highest-risk patients, such as dialysis or oncology.

Phone, portal or automated alerts

Telephone is still the main way critical results reach clinicians, though electronic alerts are growing. A 2026 review lists notification fatigue, delays and inconsistent follow-up as persistent challenges.

The CDC’s Laboratory Medicine Best Practices review recommends call centers as an evidence-based practice for timely critical value reporting in inpatient settings. It describes the evidence for automated systems as suggestive but not sufficient for a recommendation. It also says automated systems need two-way acknowledgment, escalation after failed attempts and staff skilled in manual backup.

GP47 lists similar needs: a reliable messaging system, active acknowledgment, a robust escalation procedure and downtime procedures.

How to review whether your thresholds work

Track two things. GP47’s key metrics are reliability, meaning the percentage of successful reports, and timeliness, measured as the average or median minutes to communicate and the percentage of reports within target. It also says every communication failure should be a key event requiring root cause analysis.

The 2026 review goes a step further. It suggests quality indicators should cover the timeliness of the clinical response as well as the timeliness of notification. A call at minute 10 does not help if no one acts until the next day.

A simple annual review for your practice:

• Pull every alert call from the past year and sort by test.
• Mark which calls led to a clinical action and which did not.
• Ask where thresholds are too tight (many calls, no action) or too loose (events you learned about late).
• Check contacts, escalation path and after-hours coverage.
• Send changes to the lab director in writing and document the rationale.

The Clinical Chemistry authors observe that ISO 15189:2022 dropped the explicit requirement to set critical intervals in consultation with clinicians, reflecting how large labs have become. They still say results should be adjusted to the local context. So the consultation is yours to ask for.

For drug and safety monitoring, where timing of draws drives what an alert means, see our piece on four windows for safety lab monitoring. If the question is how fast a result reaches you after verification, see our STAT lab order workflow.

Alert thresholds in clinical research

Trial laboratories face an added layer. A protocol may define its own safety limits, a sponsor may ask for notification of particular values, and an investigator site still needs routine clinical alerts for patient safety. These can overlap or differ.

The workable approach is to settle it in writing before the first sample ships:

• Agree which list governs which result: the laboratory’s routine list, the protocol’s list, or both.
• Name who is called at the site, at the sponsor or CRO, and in what order.
• Define time frames and after-hours routes for each tier.
• Keep cutoffs consistent across sites and labs. Our guide to biomarker cutoff harmonization covers how.
• Confirm how results used for clinical decisions are separated from research-only testing. See CLIA for research testing.

Because protocols differ, check your specific protocol and your IRB or sponsor requirements for the governing rules.

Perspective

We see alert thresholds as a service agreement as much as a laboratory setting. A list that nobody on the clinical side has read is only a list. A list that has been talked through with the practice, reflecting its patients and its after-hours reality, is a safety tool.

That is why we put direct communication at the center of how we work with practices and research sponsors. We prioritize fast turnaround, responsive contact and solutions built around each provider’s needs, so questions about who gets called, when, and for which result get answered by a person who knows your account.

Whether you use us as your primary laboratory or as an added resource for specialized testing, we welcome the conversation about your thresholds, your contacts and your escalation path before the first result is ever reported.

Kohealth Labs

Work with a lab that talks through your thresholds

KoHealth Labs is a diagnostic laboratory and clinical research partner serving physician practices, urgent care, skilled nursing and long-term care, home health, CROs and pharmaceutical sponsors. Our services include clinical and molecular testing, specimen pickup, mobile phlebotomy, electronic results reporting and LIS and EHR integration.

If you want to review how results and notifications would reach your team, start with our faster diagnostics page. Research teams can look at our clinical trials laboratory services, or you can visit KoHealth Labs to talk with us.

FAQ

Is a lab alert threshold the same as a critical value?

Not always. Many labs use “critical” or “panic” for life-threatening results and “alert” or “significant-risk” for results that need review sooner than routine reporting. CLSI GP47 separates the two categories and gives each its own time frame. Ask your lab how its list names and tiers them.

Who decides where the thresholds are set?

In U.S. labs, the laboratory director creates the list, in consultation with clinicians and, in CAP-accredited labs, with the approval of the medical staff. Thresholds can differ by population, such as neonates or dialysis patients. Practices should ask to see the list and give feedback.

How fast must a lab report a critical result?

CLIA requires immediate alerting of the requester for life-threatening, panic or alert values, but it does not give a number of minutes. CLSI GP47 recommends reporting immediately life-threatening results without delay and within a maximum of one hour from verification. Individual labs set their own written time frames.

Can a clinician opt out of critical result calls?

CAP strongly discourages it. The notification duty rests on the laboratory, and an opt-out removes a safeguard for the patient. A better route is to ask the lab director to review thresholds that generate calls without clinical action.

Sources

• CLSI GP47: Management of Critical- and Significant-Risk Results (sample, reaffirmed 2019)
• CLSI GP47 (2015) sample document, performance metrics and automated notification
• Truijens et al. (2024), Critical Results in Laboratory Medicine, Clinical Chemistry
• Truijens et al. (2026), Critical result thresholds and notification practices
• Pathology Consultation on Reporting of Critical Values
• Consensus Statement for the Management and Communication of High Risk Laboratory Results
• Campbell et al. (2016), What Alert Thresholds Should Be Used to Identify Critical Results
• ASCP practice parameter: Critical values
• CAP Report Elements (2019)
• CDC Laboratory Medicine Best Practices: Reporting Critical Values
• Nationwide Children’s Hospital: Critical Alert Results Reporting
• 42 CFR §493.1291, Test report

For more information about our diagnostic testing, clinical research laboratory services, or partnership opportunities, visit https://kohealthlabs.com or contact KoHealth Labs at (469) 792-8439 and ask for Amy Patterson.